Works matching IS 17762596 AND DT 2024 AND VI 19 AND IP 1

Results: 14

Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea.

Published in:

Targeted Oncology, 2024, v. 19, n. 1, p. 41, doi. 10.1007/s11523-023-01022-z

By:

Shin, Yeokyeong;
Moon, Bo Hyun;
Ryoo, Baek-Yeol;
Chang, Heung-Moon;
Kim, Kyu-pyo;
Hong, Yong Sang;
Kim, Tae Won;
Ryu, Jin-Sook;
Kim, Yong-il;
Yoo, Changhoon

Publication type:

Article

Prognostic Impact of HER2-Low and HER2-Zero in Resectable Breast Cancer with Different Hormone Receptor Status: A Landmark Analysis of Real-World Data from the National Cancer Center of China.

Published in:

Targeted Oncology, 2024, v. 19, n. 1, p. 81, doi. 10.1007/s11523-023-01030-z

By:

Dai, Qichen;
Feng, Kexin;
Liu, Gang;
Cheng, Han;
Tong, Xiangyu;
Wang, Xiang;
Feng, Lin;
Wang, Yipeng

Publication type:

Article

Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma.

Published in:

Targeted Oncology, 2024, v. 19, n. 1, p. 29, doi. 10.1007/s11523-023-01029-6

By:

Camera, Silvia;
Rimini, Margherita;
Rossari, Federico;
Tada, Toshifumi;
Suda, Goki;
Shimose, Shigeo;
Kudo, Masatoshi;
Yoo, Changhoon;
Cheon, Jaekyung;
Finkelmeier, Fabian;
Lim, Ho Yeong;
Presa, José;
Masi, Gianluca;
Bergamo, Francesca;
Salani, Francesca;
Marseglia, Mariarosaria;
Amadeo, Elisabeth;
Vitiello, Francesco;
Kumada, Takashi;
Sakamoto, Naoya

Publication type:

Article

Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer.

Published in:

2024

By:

Fung, Simon;
Syed, Yahiya Y.

Publication type:

Correction Notice

Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma.

Published in:

Targeted Oncology, 2024, v. 19, n. 1, p. 115, doi. 10.1007/s11523-023-01026-9

By:

France, Nicole L.;
Blair, Hannah A.

Publication type:

Article

Correction to: Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis.

Published in:

2024

By:

Maiorano, Brigida Anna;
De Giorgi, Ugo;
Verzoni, Elena;
Maiello, Evaristo;
Procopio, Giuseppe;
Conteduca, Vincenza;
Di Maio, Massimo

Publication type:

Correction Notice

Pemigatinib: A Review in Advanced Cholangiocarcinoma.

Published in:

Targeted Oncology, 2024, v. 19, n. 1, p. 107, doi. 10.1007/s11523-023-01024-x

By:

Frampton, James E.

Publication type:

Article

Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08).

Published in:

Targeted Oncology, 2024, v. 19, n. 1, p. 51, doi. 10.1007/s11523-023-01028-7

By:

Wang, Hung-Ming;
Lou, Pei-Jen;
Yang, Muh-Hwa;
Chen, Tein-Hua;
Lien, Ming-Yu;
Lin, Jin-Ching;
Chen, Jo-Pai;
Lu, Wei-Chen;
Lu, Hsueh-Ju;
Huang, Tai-Lin;
Yen, Chia-Jui;
Wu, Shang-Yin;
Wang, Hui-Ching;
Hsieh, Meng-Che

Publication type:

Article

Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer.

Published in:

Targeted Oncology, 2024, v. 19, n. 1, p. 59, doi. 10.1007/s11523-023-01027-8

By:

Sunakawa, Yu;
Kuboki, Yasutoshi;
Watanabe, Jun;
Terazawa, Tetsuji;
Kawakami, Hisato;
Yokota, Mitsuru;
Nakamura, Masato;
Kotaka, Masahito;
Sugimoto, Naotoshi;
Ojima, Hitoshi;
Oki, Eiji;
Kajiwara, Takeshi;
Yamamoto, Yoshiyuki;
Tsuji, Yasushi;
Denda, Tadamichi;
Tamura, Takao;
Ishihara, Soichiro;
Taniguchi, Hiroya;
Nakajima, Takako Eguchi;
Morita, Satoshi

Publication type:

Article

Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.

Published in:

2024

By:

Le, Xiuning;
Nadler, Eric;
Costa, Daniel B.;
Heymach, John Victor

Publication type:

Correction Notice

Ezurpimtrostat, A Palmitoyl-Protein Thioesterase-1 Inhibitor, Combined with PD-1 Inhibition Provides CD8<sup>+</sup> Lymphocyte Repopulation in Hepatocellular Carcinoma.

Published in:

Targeted Oncology, 2024, v. 19, n. 1, p. 95, doi. 10.1007/s11523-023-01019-8

By:

Bestion, Eloïne;
Rachid, Madani;
Tijeras-Raballand, Annemilaï;
Roth, Gael;
Decaens, Thomas;
Ansaldi, Christelle;
Mezouar, Soraya;
Raymond, Eric;
Halfon, Philippe

Publication type:

Article

A Novel Prognostic Model Using Pan-Immune-Inflammation Value and Programmed Death Ligand 1 in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Retrospective Multicenter Analysis.

Published in:

Targeted Oncology, 2024, v. 19, n. 1, p. 71, doi. 10.1007/s11523-023-01018-9

By:

Lien, Ming-Yu;
Hwang, Tzer-Zen;
Wang, Chih-Chun;
Hsieh, Ching-Yun;
Yang, Chuan-Chien;
Wang, Chien-Chung;
Lien, Ching-Feng;
Shih, Yu-Chen;
Yeh, Shyh-An;
Hsieh, Meng-Che

Publication type:

Article

Malignant Pleural Mesothelioma: Staging and Radiological Response Criteria in Patients Treated with Immune Checkpoint Inhibitors.

Published in:

Targeted Oncology, 2024, v. 19, n. 1, p. 13, doi. 10.1007/s11523-023-01017-w

By:

Martella, Serafina;
Aiello, Marco Maria;
Bertaglia, Valentina;
Cau, Riccardo;
Denaro, Nerina;
Cadoni, Andrea;
Novello, Silvia;
Scartozzi, Mario;
Novello, Giuseppe;
Soto Parra, Hector Josè;
Saba, Luca;
Solinas, Cinzia;
Porcu, Michele

Publication type:

Article

Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis.

Published in:

Targeted Oncology, 2024, v. 19, n. 1, p. 1, doi. 10.1007/s11523-023-01016-x

By:

Maiorano, Brigida Anna;
De Giorgi, Ugo;
Verzoni, Elena;
Maiello, Evaristo;
Procopio, Giuseppe;
Conteduca, Vincenza;
Di Maio, Massimo

Publication type:

Article